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Abstract
Background: Frequent home blood pressure (BP) measurements result in a better estimation of the true BP. However, traditional
cuff-based BP measurements are troublesome for patients.
Objective: This study aimed to evaluate the feasibility of a cuffless device for ambulatory systolic blood pressure (SBP)
measurement.
Methods: This was a mixed method feasibility study in patients with hypertension. Performance of ambulatory SBPs with the
device was analyzed quantitatively by intrauser reproducibility and comparability to a classic home BP monitor. Correct use by
the patients was checked with video, and user-friendliness was assessed using a validated questionnaire, the System Usability
Scale (SUS). Patient experiences were assessed using qualitative interviews.
Results: A total of 1020 SBP measurements were performed using the Checkme monitor in 11 patients with hypertension.
Duplicate SBPs showed a high intrauser correlation (R=0.86, P<.001). SBPs measured by the Checkme monitor did not correlate
well with those of the different home monitors (R=0.47, P=.007). However, the mean SBPs measured by the Checkme and home
monitors over the 3-week follow-up were strongly correlated (R=0.75, P=.008). In addition, 36.4% (n=4) of the participants
performed the Checkme measurements without any mistakes. The mean SUS score was 86.4 (SD 8.3). The most important
facilitator was the ease of using the Checkme monitor. Most important barriers included the absence of diastolic BP and the
incidental difficulties in obtaining an SBP result.
Conclusions: Given the good intrauser reproducibility, user-friendliness, and patient experience, all of which facilitate patients
to perform frequent measurements, cuffless BP monitoring may change the way patients measure their BP at home in the context
of ambulant hypertension management.
(J Med Internet Res 2019;21(6):e11164)  doi: 10.2196/11164
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Introduction
An elevated blood pressure (BP) is a major risk factor for
cardiovascular morbidity and mortality [1]. BP is, however, a
highly variable vital parameter, and circumstances under which
measuring takes place may influence the result extensively [2-4].
Compared to office BP measurement, home BP measurement
predicts cardiovascular risk better [5-8]. The predictive value
increases progressively with the number of home measurements
[9]. Thus, to improve assessment of BP for diagnosis and
management of high BP, the BP needs to be monitored
frequently, preferably at home.
For patients with hypertension, home blood pressure monitoring
(HBPM) is easy to perform, reliable, and reproducible [10].
Therefore, it is recommended as a routine component of BP
monitoring in the American Society of Hypertension and the
American Heart Association guidelines [5]. The use of HBPM
improves hypertension control and the associated outcomes
[11-14]. At home, BP is predominantly measured with an
oscillometric BP monitor, which uses an arm cuff. In daily
practice, patients use different types of BP monitors, which, in
most cases, have been validated according to the international
standard and have been checked by their provider [15].
However, in a cross-sectional study by Ruzicka et al, 30% of
home BP monitors were found to be inaccurate with use of a
stringent criterion of 5 mm Hg difference between
measurements. Using a different threshold for accuracy
(difference of more than 10 mm Hg), 16 of 210 (8%) HBP
monitors were inaccurate for systolic BP (SBP) and 18 (9%)
were inaccurate for diastolic BP [16]. Although an automatic
BP monitor is relatively easy to use and inexpensive [5],
measuring BP is time-consuming and may be perceived as
inconvenient. In addition, various factors may influence the
accuracy of measuring BP, such as discomfort by inflation of
the cuff [17] and inappropriate cuff size and cuff position at the
arm in relation to the heart level [18].
A new technique has been developed to measure SBP fast and
easy without the use of a cuff, which is applied in new devices
such as the Checkme Pro Health Monitor (Shenzhen Viatom,
China). An algorithm calculates the SBP based on the pulse
transit time determined by the peripheral capillary oxygen
saturation (SpO2) measurement (an estimate of the amount of
oxygen in the blood and is the percentage of oxygenated
hemoglobin compared to the total amount of hemoglobin in the
blood), the electrical electrocardiogram (ECG) signal, and the
individual’s arterial compliance [19]. For the latter, the cuffless
device needs a calibration procedure, which is developed by
entering a classically obtained SBP. Calibration needs to be
repeated monthly. An SBP measurement with the Checkme
monitor takes less than 30 seconds, which could increase the
willingness of patients to measure their SBP more frequently.
Cuffless BP measurement is an emerging technique, which may
lead to an increased patient compliance in measuring BP at
home and promoting a larger number of BP results for
hypertension management. Moreover, the Checkme monitor
captures a single-lead ECG and photoplethysmogram signal in
the same 30 seconds.
Recently, we evaluated the validity of the Checkme monitor’s
SBP results by using criteria of the European Society of
Hypertension for validating new BP devices [20]. This validation
protocol may be considered inadequate, as it lacks consensus
about the quality of the BP measurement to be used for
calibrating cuffless devices. However, results obtained with the
Checkme monitor were promising over a wide range of BP
levels [20]. A recent study showed promising results of vital
parameter measurements in an inpatient setting [21]. Since the
previous study by Schoot et al was performed under demanded
controlled circumstances, there was a need to evaluate the
performance of the Checkme monitor in an uncontrolled home
setting.
To assess feasibility of the Checkme monitor in an outpatient
setting, we studied the performance, user-friendliness, and
patient experience of the Checkme me in participants’ home
settings.
Methods
Research Design, Setting, and Participants
We conducted a pilot study using a mixed method approach.
To determine performance of the SBP measurement, we
systematically assessed the reproducibility of the Checkme
monitor, its comparability to a home BP monitor, and the
performance of daily vital measurements with the Checkme
monitor using video analysis. A System Usability Scale (SUS)
questionnaire was used to determine the user-friendliness.
Patient experience was assessed using a semistructured interview
following the Unified Theory of Acceptance and Use of
Technology 2 (UTAUT2) framework. Participants were
recruited from the hypertension outpatient clinic of an academic
hospital in The Netherlands from April 2017 to May 2017. The
institutional review board approved the study (ID: 2017-3241).
All participants provided signed informed consent after written
and verbal information were obtained.
Inclusion and Exclusion Criteria
Patients were considered eligible if they were receiving medical
treatment for high BP, accustomed to home BP measurements
with their own blood pressure monitor, of age ≥ 18 years, and
had the cognitive ability to understand instruction and perform
measurements correctly after instruction. Patients with a
pacemaker and pregnant women were excluded.
The Checkme Pro Health Monitor
We evaluated the Checkme Pro Health Monitor, which measures
SBP without the use of a cuff. The device also measures a
one-lead ECG, heart rate, and SpO2 in one measurement called
“daily check.” The method of measurement of these vitals by
the Checkme monitor is shown in Figure 1. The right thumb,
right middle finger, and left palm are placed on the ECG sensors.
The right index finger is placed on the built-in SpO2 sensor. To
increase accuracy of the results, the device needs to be held
steady at the heart level during the measurement. The latest
version of the Checkme monitor, used in this study, is cleared
by the US Food and Drug Administration (FDA) for measuring
these vitals (FDA 510k release: K150869; Device Name:
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CheckMe Pro Health Monitor; Regulation Number: 21 CFR
870.2300; Regulation Name: Cardiac Monitor Including
Cardiotachometer and Rate Alarm; Regulatory Class: Class II;
Product Code: MWI on November 6, 2015) and complies with
the Conformité Européene (CE) marking medical devices
directive (CE certificate was issued on behalf of TüV Rheinland
LGA Products GmbH notified body [CE 0197] on Viatom’s
Health Monitor models “Checkme Pro, Plus, Pod, and Lite”
[standard MDD 93/42/EEC, Annex II; Certificate HD60107767
0001; April 27, 2016]).
Figure 1. Demonstration of a systolic blood pressure measurement using the Checkme Pro Health Monitor. The right thumb, middle finger, and left
palm are placed on the electrocardiogram sensors. The right index finger is placed on the built-in SpO2 (peripheral capillary oxygen saturation) sensor.
Systolic blood pressure measurement is performed in less than 30 seconds, holding the device steady at heart level.
Study Procedures
The study timeline and procedures are shown in Figure 2. Two
trained researchers instructed the participants on the study
procedures and how to perform the SBP measurement with the
Checkme monitor, and checked the way they performed their
regular home SBP measurement using their own home BP
monitor. Before the start of the study, the Checkme monitor
was calibrated for SBP measurement according to
manufacturer’s instructions. To determine a reference SBP to
calibrate the Checkme monitor, a standard duplicate BP
measurement was performed using a validated automatic BP
monitor at the outpatient clinic (Vital Signs Monitor 300 series,
Welch Allyn, Skaneateles Falls, NY) after an initial 5 minutes
of rest. The participants performed the measurements with the
Checkme monitor in duplicate twice daily, in the morning and
evening, for a period of 3 weeks. They were instructed to
perform the second measurement immediately after the first
measurement under the same circumstances.
In addition, the participants performed regular BP measurement
once weekly with their own home BP device. Participants were
asked to perform one duplicate SBP measurement with the
Checkme monitor and one duplicate home BP measurement
using their own conventional BP monitor, in a random order.
After 3 weeks, the correct use of the Checkme monitor by the
patient was checked with a video recording of the SBP
measurement. The user-friendliness was assessed using the SUS
questionnaire, and the patient’s experience was determined with
a semistructured interview.
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Figure 2. Timeline of the study procedures. Dotted lines represent a variable time of 0-5 days between day X and day 0, and 0-5 days between the end
of the study period and day Y. BP: blood pressure; SBP: systolic blood pressure; SUS: System Usability Scale.
Analysis of Reproducibility
To obtain the intrauser reproducibility of a duplicate SBP
measurement, two values of one duplicate measurement were
correlated and the level of variation was categorized as <5 mm
Hg, <10 mm Hg, and >15 mm Hg. Both the Checkme and home
BP monitors were tested for reproducibility. The paired SBP
measurements with the Checkme monitor and home BP monitor
were correlated to obtain comparability. The mean difference
and level of variation in SBP measurements between the
Checkme and home BP monitors were calculated. In addition
to the paired measurements, the means of all SBP measurements
with the Checkme and home BP monitors were correlated. For
each participant, all SBP values measured with the Checkme
monitor, their home BP monitor, and the hospital monitor were
plotted in a diagram to show the variation of SBP over time
measured with different devices.
Analysis of the Correct Use of Checkme by the Patient
Two researchers independently assessed the use of Checkme
by the patient, by checking the video-recorded measurements
with a scoring sheet based on the principles of Gelbart et al [22]
and Van Der Heide et al [23]. Thirteen steps were distinguished
for the SBP measurement with the Checkme monitor. All items
for the use of the Checkme monitor were categorized as “badly
performed” or “not done” (0 points), “suboptimal” or “too late”
(1 point), and “perfectly done” (2 points). Findings were
compared and discussed until a consensus was reached.
Analysis of Patient Experience
The semistructured interviews following the UTAUT2
framework [24] (Figure 3) were conducted in Dutch with the
participants. The UTAUT2 framework consists of four major
themes: performance expectancy, effort expectancy, social
influence, and facilitating conditions. Performance expectancy
is defined as the degree to which an individual believes that
using the Checkme monitor will help him/her. Effort expectancy
is defined as the degree of ease associated with the use of the
Checkme monitor. Social influence is defined as the degree to
which an individual perceives that significant others believe
he/she should use Checkme. Facilitating conditions are defined
as the degree to which an individual believes that an
organizational and technical infrastructure exists to support the
use of the Checkme monitor [25].
Interviews were audio recorded and transcribed verbatim using
qualitative data analysis software (ATLAS.ti 7.1, Scientific
Software Development GmbH, Berlin, Germany). Transcripts
were independently analyzed by two investigators to identify
barriers, facilitators, and positive and negative effects of the use
of the Checkme monitor. Findings were discussed until a
consensus was achieved. The barriers and facilitators were
rewritten into general statements and subdivided according to
the themes of the UTAUT2 interview framework. The
magnitude of each statement was determined by the number of
interviews the statement was mentioned in. A validated Dutch
translation [26] of the SUS questionnaire [27] on the usability
of the Checkme monitor was used to determine the
user-friendliness, scored between 0 and 100, as described by
Brooke et al [27]. The interpretation of the SUS score was in
accordance with that provided by Bangor et al [28]. A score
above 90.9 was considered “best imaginable,” a score above
85.5 was considered “excellent,” a score above 71.4 was
considered “good,” a score above 50.9 was considered
“sufficient,” and a score below or equal to 50.9 was considered
“poor.”
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Figure 3. Interview framework of the Unified Theory of Acceptance and Use of Technology 2.
Statistical Analyses
All statistical analyses were performed using IBM SPSS, version
22.0 (IBM Corp, Armonk, NY). Normally distributed data were
presented as mean and SD. Descriptive statistics were presented
as median and quartiles in case of nonnormally distributed data.
Differences were tested using a t test in case of normal
distribution of the data and the nonparametric Wilcoxon test in
case of nonnormally distributed data. Correlations were
calculated with the Spearman rank correlation coefficient.
Results
User Statistics
One of 12 participants enrolled in the study was excluded from
participation and analysis due to repeated failure of BP
calibration. One participant did not own a BP monitor and
visited the hospital for weekly BP measurements. Average
instruction time was 20-40 minutes. The characteristics of the
11 participants who completed the study period are summarized
in Table 1. The SBP readings of the participants’ home BP
monitors strongly correlated with those of the automatic hospital
BP monitor at baseline (R=0.88, P<.001). Eleven participants
performed a total of 1020 measurements with the Checkme
monitor. In 209 measurements (20.4%), the Checkme monitor
was not able to measure the SBP. The success rate for SBP
measurement varied among participants, with a mean success
of 71%, ranging from 42% to 100%.
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Table 1. Participant characteristics (N=11).
Study populationCharacteristics
 Gender, n (%)
4 (36)Female 
7 (64)Male 
 Ethnicity, n (%)
10 (91)Caucasian 
1 (9)Black 
57 (11.5)Age (years), mean (SD)
140.7 (13.7)Systolic BPa (mm Hg), mean (SD)b
86.3 (11.0)Diastolic BP (mm Hg), mean (SD)b, c
9 (82)Use of BP-lowering medication, n (%)
10 (91)Use of home monitor, n (%)
Brand, nd
3Withings 
2Microlife 
1Omron 
1Beurer 
1A&D Medical 
1Medion 
1Cresta 
6.8 (6.2)Frequency per month, mean (SD)
aBP: blood pressure.
bBP measured by trained investigator with a Welch Allyn Automatic BP monitor at day 0.
cData shown for only 10 patients, because of the lack of diastolic BP data in one patient.
dN=10.
Reproducibility
The paired results of duplicate SBP measurements of the
Checkme monitor correlated well over the whole range of BP
levels (R=0.86, P=.001). Of the 420 complete duplicate SBPs,
paired results of 374 (89%) duplicates varied within 10 mm Hg,
of which 286 (68% of total) varied within 5 mm Hg. Paired
results of 22 (5%) duplicate SBPs varied more than 15 mm Hg.
Variations of the paired results of duplicates are shown in Figure
4. Of the 22 duplicates with a difference of more than 15 mm
Hg, 11 were obtained from only two participants. The paired
results of duplicate SBP measurements with the home BP
monitors correlated strongly (R=0.91, P<.001). Of the 40
complete duplicate SBPs, 38 (95%) varied within 10 mm Hg,
of which 27 (67% of total) varied within 5 mm Hg. No
measurement exceeded a variation of 15 mm Hg. For each
participant, all SBP values measured with the Checkme monitor
(twice daily), the home BP monitor (once weekly), and the
hospital monitor (once) are plotted in Figure 5.
The measurements of the Checkme and home BP monitors
correlated weakly (R=0.47, P=.007). The mean results of the
paired measurements with the Checkme monitor were 0.55 mm
Hg (SD 12.32) higher than those of the home BP monitors. Of
the 32 paired SBP values, there was a difference between the
Checkme and home BP monitors of <5 mm Hg in 7 pairs (22%),
<10 mm Hg in 18 pairs (56%), and <15 mm Hg in 26 pairs
(81%).
The mean SBP of both devices over 3 weeks correlated strongly
(R=0.75, P=.008). The Checkme monitor had a mean systematic
difference of 0.26 mm Hg (SD 7.66) for mean SBP over 3 weeks
compared to the home BP monitors. In addition, 36.3% of the
mean SBP measurements with the Checkme and home BP
monitors varied within 5 mm Hg and 90.9% varied within 10
mm Hg. No measurement exceeded a variation of 15 mm Hg.
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Figure 4. Frequency of the difference within duplicate SBP measurements. SBP: systolic blood pressure.
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Figure 5. Systolic blood pressure during follow-up for each participant, measured with Checkme and home BP monitor or hospital BP monitor. BP:
blood pressure.
Correct Use of the Checkme Monitor
In total, 36.4% (n=4) of the participants performed the
measurement with the Checkme monitor correctly (“well done”)
in all 13 items, 54.5% (n=6) performed the measurement with
one mistake, and 9.1% (n=1) performed the measurement with
two mistakes. No participants made more than two mistakes.
The most frequent mistake was not keeping the Checkme
monitor at heart level (5/11). During video recording, 1 of the
11 participants did not receive a valid SBP result. The hands of
this participant were shaking due to the side effects of the
medication, and he did not find support by resting his arms on
the table. However, at home, this participant achieved a valid
SBP in 80 of 104 measurements (77%).
Patient Experience
Interviews lasted for 15-35 minutes. All perceived barriers and
facilitators could be subdivided into one of the five themes of
the UTAUT2 interview framework. Most significant barriers
and facilitators are described here, and all barriers and
facilitators are summarized in Table 2.
Performance expectancy could be divided into two subsequent
topics: the features and possibilities of the Checkme monitor
and the measurement results produced by the Checkme monitor.
For the possibilities of the Checkme monitor, six participants
perceived the inability of Checkme to measure DBP as a barrier.
They considered DBP to be as important as SBP. At times, the
Checkme monitor did not report a result for SBP, which was a
barrier for seven participants. This was sometimes perceived
as bothersome, since the cause was unclear and the measurement
had to be repeated. Another barrier mentioned by three
participants was the occasional big difference in SBP measured
with the Checkme monitor compared to the home or hospital
BP monitor. This reduced their trust in Checkme’s performance.
One participant, on the other hand, reported that the Checkme
and home BP monitors correlated well, which increased her
trust in the Checkme monitor.
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Table 2. Barriers and facilitators for use of the Checkme monitor and the number of interviews these were mentioned in, according to the themes of
the Unified Theory of Acceptance and Use of Technology 2 interview framework and subsequent topics.
FacilitatorBarrierVariable
116Performance expectancy
Possibilities of Checkme
06The device measures only SBPa
Outcomes of Checkme
07At times, the Checkme did not report a result for SBP and/or SpO2b
13The big/small difference between the home BPc monitor and the Checkme leads to less/more trust in the Checkme
227Effort expectancy
Performing measurements
110The Checkme is easy to use
41With the Checkme, a measurement is quickly performed
30BP can be measured with the Checkme without the use of an arm cuff
01Daily check cannot be performed with cold hands
Design of Checkme
40The Checkme is small and can be taken everywhere
02The Checkme does not have a backlight in the touch screen
02The Checkme is not a standard BP monitor, which decreases trust in results
01The font size of the results screen is very small
10Social influence
10Measuring BP with the Checkme can be done without any help
aSBP: systolic blood pressure.
bSpO2: peripheral capillary oxygen saturation.
cBP: blood pressure.
Effort expectancy was defined through two topics: performing
measurements and the design of the Checkme monitor. For
performing measurements, all participants considered the
Checkme monitor easy to use and four could quickly perform
a measurement. Three participants perceived the Checkme
monitor to be a facilitator that can measure SBP without the
use of an arm cuff, mostly because the arm cuff on their home
BP monitor was uncomfortable. Regarding the design of the
Checkme monitor, the most significant facilitator perceived was
the small size of the device (n=4).
In addition, three participants thought the Checkme monitor
would be unsuitable for the elderly, because of their decreased
fine motor skills. Automatic synchronization of results was
preferred by eight participants, either to their medical record or
an online app, to be able to monitor the results of medication,
diet, and physical activities and discuss the results with their
doctor. Two other suggestions were increasing the font size and
addition of a backlight to the screen.
Five participants wanted to use the Checkme monitor in the
future instead of their own home BP monitor. Three other
participants wanted to use the Checkme monitor in the future
only on certain conditions, for example, if the device reports
reliable results. The remaining three participants did not want
to use Checkme in the future. Eight participants would
recommend the Checkme monitor to other patients. Participants
gave the monitor a median score of 7.5 (interquartile range:
5.0-8.0) on a scale of 1 to 10, with individual scores ranging
from 1.0 to 9.0. The mean SUS score was 86.4 (SD 8.3) with a
range of 72.5-97.5, which indicates high user-friendliness.
Discussion
Principal Findings
This study provides new insights about the use, performance,
and patient experience of an FDA-approved cuffless
BP-measuring device in patients who are used to measuring
their blood pressure at home. Adequate intrauser reproducibility
of cuffless SBP measurement was observed in the majority of
participants, and the Checkme monitor was well adopted in the
home setting. Patients indicated an increased willingness to take
their BP measurement because of its ease of use. Thus, the large
variety of cuff-based BP monitors currently used by patients in
home BP monitoring does not necessarily serve as a gold
standard to compare new devices for home monitoring. In
addition, the easily obtained large number of the Checkme SBP
measurements may provide a better picture of the actual BP
variation over time, which can be easily missed by taking only
one home measurement every week.
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The SBP measured by the Checkme monitor was comparable
to that measured by an in-hospital reference monitor, with a
mean difference of 2.6 (SD 12.1) mm Hg [20]. Other studies
compared different cuffless SBP-measuring devices to a
reference monitor. Poon et al [29] described a mean difference
of 0.6 (SD 9.8) mm Hg, and Boubouchairopoulou et al [30]
found a mean difference of 3.2 (SD 6.7) mm Hg, which is, to
a great extent, comparable to the results of this study. In
addition, this study showed that currently, an unrestricted range
of BP monitors from different manufacturers are being used for
home BP monitoring. Both the variety of home BP monitors
and the uncontrolled use in a home setting may contribute to
the observed differences. Although home BP devices should
ideally be on the list of validated monitors and the circumstances
under which measurements are taken should be standardized,
the added value of home BP monitoring is the increasing number
of results, not the absolute value of each of them [31]. Robust
hypertension management is based on the average of a large
series of BP measurements rather than a single clinic
measurement [31]. The majority of participants could produce
a series of valid measurement results, and most of the
unsuccessful SBP measurement attempts were observed in a
small number of participants. Failure to produce valid SBP
readings may be caused by several factors. Since the cuffless
technique requires an ECG and SpO2 signal to produce an SBP
result, factors influencing ECG and SpO2 accuracy may lead to
unsuccessful measurements with no SBP results. These factors
include poor perfusion (cold fingers) and skin color [32,33].
Performance-related factors such as moving during the
measurement or applying too much pressure on the sensors [34]
may disturb the SpO2 signal and thereby influence the SBP
result, which suggests that proper user instructions are necessary.
Technical factors such as system failure, incorrect calibration
procedure, or imperfections in the algorithm may also influence
the BP results.
Another issue of the cuffless BP measurement technique is the
need of a classic reference BP measurement to calibrate the
calculating algorithm for individual vascular compliance. An
international standard for this calibration procedure is still
lacking in existing protocols for new BP device validation [35].
Schoot et al [20] recently performed a pragmatic validation
study with the Checkme monitor by using standardized
measurement conditions, which revealed promising results.
Despite its easy-to-use concept, accurate self-measuring with
the Checkme monitor was not completely adequate after a single
instruction at the start of this study. This phenomenon was also
observed in studies with conventional BP monitors, which
reported that 52%-65% of patients missed at least one step of
the BP measurement process [36,37]. Milot et al found that only
18% of patients performed the classic BP measurement with
cuff with excellence [38], and Wagner et al found that none of
the participants performed BP measurement correctly [39].
Compared with these observations in classical cuff-based BP
measurement, the correct use of the Checkme monitor in our
study was much better. The only observed mistake was not
holding the device at the heart level, which has a minor effect
on the SBP result [20]. Other mistakes concerning the use of
the Checkme monitor were not observed. This is in contrast to
the observation during classic BP measurement, in which various
other errors, with respect to cuff usage and position, can occur.
An important finding of the present study is that user instruction
needs attention, both at the start and during long-term use, to
increase the quality of BP readings. This may be achieved by
optimizing the patient instruction by using the protocol described
by Mengden et al as a guide [40] or using video instructions
[41].
Performance expectancy and effort expectancy were most
mentioned in the interviews, and only a few barriers and
facilitators were mentioned on social influence and facilitating
conditions. This can be explained by the short follow-up period
and the fact that Checkme is a new unknown device. The two
most prominent issues of performance expectancy for
participants are that the Checkme monitor only measures SBP
and not DBP, and the monitor sometimes fails to produce a
valid SBP result. The cuffless BP measurement technique is
currently unable to determine DBP accurately. However, it is
internationally accepted that SBP is the primary target in
managing cardiovascular risk in most patient groups, except in
elderly people [42]. Some participants also suggested improving
the design of the Checkme monitor. Although requirements for
medical devices are dictated by appropriate legislative bodies
such as the European directive (93/42/EEC, the Medical Devices
Directive) for the European devices, five requirements for home
monitoring with wearable sensors have been described by
Korhonen et al: reliability and durability, looks and
unobtrusiveness, user identification, communication, and zero
maintenance and fault recovery [43]. Cuff-based home BP
monitors meet the first and last requirement. The Checkme
monitor formally meets the second, third, and fourth criteria
with its size, personal user profiles, and ability to share readings,
respectively. This study also provides new information about
the reliability through its evaluation of intrauser reproducibility
of the Checkme monitor in home monitoring. The memory
capacity of the Checkme monitor and the ability to automatically
share saved readings bypasses the imprecision of self-reported
BP readings by patients, which appeared to range from 0% to
100% in a study on 30 patients with hypertension [44]. Further,
it enables physicians to intervene and adjust medication, since
patients are often not able to interpret the readings of SBP
correctly [45,46].
Strengths and Limitations
The strength of this pilot study is that SBP was measured by
the cuffless Checkme device in a home-based setting. This is
the first study in which the feasibility, usability, and
acceptability of a cuffless BP measuring device in a home
monitoring setting were assessed using a mixed method study
design. We obtained a large number of home measurements in
the morning and evening, as recommended by the European
Society of Hypertension/European Society of Cardiology [47]
for well-instructed patients who were involved in
self-management. Patient experience and performance were
evaluated by a widely used and reliable questionnaire to
determine the feasibility of different products, and all interviews
followed an interview guide derived from a well-known
interview framework [28,48]. A weakness of this study was the
small study sample, which may not guarantee complete
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saturation in all qualitative aspects. The relative short follow-up
may also have led to an incomplete user experience. In addition,
the fact that medication use may instantly influence
measurements could induce device-independent differences.
However, the blood pressure results that were compared were
based on daily averages or were time-related (measurement
with both devices at the same time). To confirm the current
results, this study should be repeated on a larger scale. Some
adjustments of the methods need to be taken into consideration,
including more explicit user instructions and a restricted set of
validated home BP monitors as a reference. Future studies
should focus on the cause and mechanisms of failures to measure
SBP with Checkme in some patients or settings. Furthermore,
an international validation protocol for the calibration procedure
of a cuffless device is needed. The Institute of Electrical and
Electronics Engineers Standard for Wearable Cuffless Blood
Pressure Measuring Devices [49] should incorporate a norm for
such devices.
Implications for Practice
It is highly possible that the use of cuffless SBP devices will
become part of common practice in hypertension and
cardiovascular risk management in the near future. Therefore,
health care professionals should be aware of this development
and familiarize themselves with the specific characteristics of
these devices. They could explore possibilities such as smart
data analysis and connectivity with electronic health records.
Patients and their relatives should not hesitate to discuss the
possibilities in home monitoring with their health care
professionals. If they start using these devices, it may provide
them with better insight into their health status and recovery,
with minimum effort.
Conclusions
As confidence in BP measurement results continues to increase,
and if international consensus on the calibration process is
reached, cuffless BP monitoring devices such as the Checkme
monitor may change the way patients measure their BP at home,
in the context of ambulant hypertension and cardiovascular risk
management. A major advantage of the Checkme monitor in
addition to the current use of cuff-based BP home monitors is
that the former stimulates the patient in taking a larger number
of BP readings because of its easy-to-use design.
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